caprylates has been researched along with Cognition Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howland, RH | 1 |
Alkon, DL; Hongpaisan, J; Sun, MK | 1 |
Kanno, T; Nishizaki, T; Shimizu, T; Tanaka, A; Yaguchi, T | 1 |
Baccarelli, AA; Power, MC; Webster, TF; Weisskopf, MG | 1 |
Shah, S; Tear, S | 1 |
5 other study(ies) available for caprylates and Cognition Disorders
Article | Year |
---|---|
Drug therapies for cognitive impairment and dementia.
Topics: Aged; Caprylates; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Food, Formulated; Ginkgo biloba; Glutamic Acid; Humans; Nootropic Agents; Phytotherapy; Plant Extracts; Receptors, N-Methyl-D-Aspartate; Triglycerides | 2010 |
PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Bryostatins; Caprylates; Cognition Disorders; Enzyme Activators; Hippocampus; Isoenzymes; Male; Maze Learning; Memory; Mice; Mice, Transgenic; Plaque, Amyloid; Protein Kinase C-alpha; Protein Kinase C-epsilon; Synapses | 2011 |
8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.
Topics: Aging; Animals; Caprylates; Cholinesterase Inhibitors; Cognition Disorders; Galantamine; Male; Memory Disorders; Mice | 2012 |
Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey.
Topics: Aged; Aged, 80 and over; Alkanesulfonic Acids; Caprylates; Causality; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Environmental Exposure; Female; Fluorocarbons; Humans; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Protective Agents; Sulfonic Acids; United States | 2013 |
Progressive neurodegenerative disease and pain.
Topics: Analgesics; Animals; Caprylates; Cognition Disorders; Egtazic Acid; Humans; Neurodegenerative Diseases; Pain; Parkinson Disease; TRPV Cation Channels | 2005 |